Comparing ChAdOx1 nCoV-19 Coronavirus Vaccine (Recombinant) (Covishield) and BBV152; Bharat Biotech COVID-19 Vaccine (Covaxin) for COVID-19: Reports of Adverse Events Following Vaccination among the Indian Population

Comparing ChAdOx1 nCoV-19 Coronavirus Vaccine (Recombinant) (Covishield) and BBV152; Bharat Biotech COVID-19 Vaccine (Covaxin) for COVID-19: Reports of Adverse Events Following Vaccination among the Indian Population

Background: COVID-19 is declared a global pandemic by the WHO; vaccines were the need of the hour to reduce mortality and return to some form of normal life. The Indian government provides two vaccines as per the program; ChAdOx1 nCoV-19 and BBV152; Bharat Biotech COVID-19 vaccine. However, vaccine...

Full description

Saved in:
Bibliographic Details
Main Authors: Sukhpal Kaur, Latika Rohilla, Choro Athiphro Kayina, Jasvir Kaur, Gurpreet Kaur, Anjani Walia, Pramod Kumar, Ajay Singh, Sushma Saini, Shiv Lal Soni, Pankaj Malhotra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Indian Journal of Public Health
Subjects:
adverse events
bbv152
chadox1 ncov-19
covid-19
vaccination
Online Access:https://journals.lww.com/10.4103/ijph.ijph_505_23
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/ijph.ijph_505_23

Similar Items